SevenBridge Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.7M | Sell |
15,049
-123
| -0.8% | -$26.5K | 0.54% | 57 |
|
|
2026
Q1 | $3.04M | Sell |
15,172
-240
| -2% | -$53.2K | 0.48% | 67 |
|
|
2025
Q4 | $3.4M | Sell |
15,412
-75
| -0.5% | -$17.1K | 0.55% | 65 |
|
|
2025
Q3 | $3.61M | Sell |
15,487
-2,204
| -12% | -$449K | 0.6% | 58 |
|
|
2025
Q2 | $3.51M | Sell |
17,691
-1,192
| -6% | -$222K | 0.62% | 50 |
|
|
2025
Q1 | $3.59M | Sell |
18,883
-1,591
| -8% | -$309K | 0.71% | 41 |
|
|
2024
Q4 | $3.93M | Sell |
20,474
-418
| -2% | -$76.9K | 0.74% | 44 |
|
|
2024
Q3 | $3.64M | Buy |
20,892
+363
| +2% | +$67.7K | 0.7% | 45 |
|
|
2024
Q2 | $3.81M | Buy |
20,529
+268
| +1% | +$44.4K | 0.84% | 35 |
|
|
2024
Q1 | $3.32M | Sell |
20,261
-160
| -0.8% | -$27.6K | 0.75% | 41 |
|
|
2023
Q4 | $3.16M | Sell |
20,421
-88
| -0.4% | -$12.8K | 0.75% | 41 |
|
|
2023
Q3 | $3.06M | Buy |
20,509
+415
| +2% | +$60.9K | 0.79% | 41 |
|
|
2023
Q2 | $2.71M | Buy |
20,094
+126
| +0.6% | +$18.5K | 0.7% | 45 |
|
|
2023
Q1 | $3.18M | Buy |
19,968
+390
| +2% | +$59.6K | 0.88% | 35 |
|
|
2022
Q4 | $3.16M | Buy |
19,578
+155
| +0.8% | +$23.8K | 0.93% | 37 |
|
|
2022
Q3 | $2.61M | Buy |
19,423
+7,915
| +69% | +$1.14M | 0.88% | 37 |
|
|
2022
Q2 | $1.76M | Sell |
11,508
-13
| -0.1% | -$1.99K | 0.71% | 42 |
|
|
2022
Q1 | $1.87M | Sell |
11,521
-1,645
| -12% | -$239K | 0.66% | 43 |
|
|
2021
Q4 | $1.78M | Buy |
13,166
+1,868
| +17% | +$221K | 0.54% | 50 |
|
|
2021
Q3 | $1.22M | Sell |
11,298
-303
| -3% | -$34.6K | 0.41% | 67 |
|
|
2021
Q2 | $1.31M | Buy |
11,601
+732
| +7% | +$82.4K | 0.43% | 68 |
|
|
2021
Q1 | $1.18M | Buy |
10,869
+484
| +5% | +$51.8K | 0.43% | 67 |
|
|
2020
Q4 | $1.11M | Buy |
10,385
+1,835
| +21% | +$176K | 0.44% | 64 |
|
|
2020
Q3 | $749K | Buy |
8,550
+142
| +2% | +$13.4K | 0.34% | 76 |
|
|
2020
Q2 | $825K | Sell |
8,408
-280
| -3% | -$24.7K | 0.41% | 66 |
|
|
2020
Q1 | $662K | Buy |
8,688
+891
| +11% | +$75.9K | 0.38% | 68 |
|
|
2019
Q4 | $690K | Buy |
7,797
+617
| +9% | +$51.2K | 0.18% | 87 |
|
|
2019
Q3 | $544K | Sell |
7,180
-517
| -7% | -$35.4K | 0.29% | 80 |
|
|
2019
Q2 | $560K | Buy |
7,697
+460
| +6% | +$36.2K | 0.2% | 87 |
|
|
2019
Q1 | $583K | Sell |
7,237
-131
| -2% | -$10.7K | 0.22% | 83 |
|
|
2018
Q4 | $679K | Sell |
7,368
-16,706
| -69% | -$1.47M | 0.42% | 65 |
|
|
2018
Q3 | $2.28M | Sell |
24,074
-189
| -0.8% | -$17.9K | 1.21% | 23 |
|
|
2018
Q2 | $2.25M | Buy |
24,263
+496
| +2% | +$48.4K | 1.25% | 22 |
|
|
2018
Q1 | $2.25M | Buy |
23,767
+60
| +0.3% | +$6.59K | 1.29% | 21 |
|
|
2017
Q4 | $2.29M | Sell |
23,707
-501
| -2% | -$47.2K | 1.27% | 19 |
|
|
2017
Q3 | $2.15M | Buy |
24,208
+819
| +4% | +$62.3K | 1.23% | 19 |
|
|
2017
Q2 | $1.7M | Buy |
23,389
+9,798
| +72% | +$659K | 1.04% | 27 |
|
|
2017
Q1 | $891K | Sell |
13,591
-3,301
| -20% | -$208K | 0.59% | 55 |
|
|
2016
Q4 | $1.03M | Hold |
16,892
| – | – | 0.75% | 40 |
|
|
2016
Q3 | $1.03M | Buy |
16,892
+970
| +6% | +$62.8K | 0.75% | 40 |
|
|
2016
Q2 | $986K | Buy |
+15,922
| New | +$970K | 0.69% | 51 |
|
Other funds holding ABBV
SevenBridge Financial Group's ABBV Position: Q2 2026 in Review
SevenBridge Financial Group reduced its AbbVie (ABBV) stake by 0.81% in Q2 2026, selling an estimated $26.5K and leaving 15,049 shares worth $3.7M. The position accounts for 0.54% of the portfolio, ranked #57.
SevenBridge Financial Group first reported a position in ABBV in Q2 2016 and has held it in 41 quarters since. The position peaked at $3.93M in Q4 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- SevenBridge Financial Group held 15,049 shares of AbbVie worth $3.7M as of Q2 2026.
- SevenBridge Financial Group sold 123 AbbVie shares in Q2 2026, an estimated $26.5K.
- AbbVie made up 0.54% of SevenBridge Financial Group's portfolio in Q2 2026, its #57 holding.
- SevenBridge Financial Group first reported a position in AbbVie in Q2 2016 and has held it in 41 quarters since.
- SevenBridge Financial Group's AbbVie position peaked at $3.93M in Q4 2024.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on SevenBridge Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.